Related Experiment Video
Updated: Apr 4, 2026
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
CCL26-Mediated Modulation of Endothelial Secretome by Hypoxia-Induced Tumor-Derived Exosomes Enhances Metastatic
Ozel Capik1,2, Sevil Tekman1,2, Betul Gundogdu3
1Department of Molecular Biology and Genetics, Erzurum Technical University, Erzurum, Turkey.
Background:
Tumor cells adapt to hypoxia by releasing hiTDExs enriched with bioactive molecules that modulate endothelial behavior and promote tumor progression. This study aimed to characterize how hypoxia-induced HNSCC exosomes reshape the endothelial secretome and contribute to metastatic potential.
Methods:
We examined whether hiTDExs reprogram endothelial cells and alter their secretome using cytokine arrays. Functional assays (migration, invasion, tube formation) showed a tumor-promoting role of CCL26 and tumor-suppressive effects of genetic inhibition of its receptor CCR3, while in silico and immunohistochemistry analyses assessed CCL26, HIF1A, and CD31 expression in relation to metastasis.
Results:
Hypoxic exosomes from Detroit-562 and FaDu cells altered 25 and 52 proteins in HUVEC secretomes, with elevated CCL26 confirmed by ELISA. CCL26 significantly enhanced HNSCC cell proliferation, migration, and invasion, whereas CCL26 neutralization or genetic inhibition of its receptor CCR3 effectively abrogated these effects. High CCL26 and HIF1A correlated with metastasis, advanced stage, and poor survival.
Conclusion:
hiTDExs reprogram endothelial secretomes by elevating CCL26, promoting tumor-supportive phenotypes and driving metastatic progression in HNSCC.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:17The Tumor Microenvironment
01:24Regulation of Angiogenesis and Blood Supply
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...